关于公司
- 法定名称: Guangdong Raffles PharmaTech Co Ltd
- 注册国家: China
- 地址: No 3, Binhai 10th Road North, Shihua Dadao Middle, Daya Bay, Huizhou, Guangdong
- 员工人数: 250 - 499
描述:
Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceutical ingredients and intermediates. We are specialized in applying organic catalysts into the process development to lower cost, and to provide cost-effective product and service to customers. With our strong R&D capability and our proprietary organic catalysts, we provide low cost and high quality active pharmaceutical ingredients and intermediates to pharmaceutical companies. We also provide world standard process development, custom synthesis and manufacturing service.
业务活动
原料药 (API)
制造商
合同与外包服务
制造商
医药化学品
制造商
合同研究组织服务 (CRO)
制造商
生物制药服务
制造商
销售市场
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
主要产品/服务
- 医药化学品: (2R,6R)-2,6-diphenyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2R)-2-Piperidine Methanamine, (3S,11aR)-N-(2,4-difluorobenzyl)-6-methoxy-3-methyl-5,7, (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a, (2S,6S)-2,6-Di-benzyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2S,6S)-2,6-Di-benzyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole HI salt, (2S,6S)-2,6-Di-tert-butyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2S,6S)-2,6-Di-tert-butyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole HI salt, (2S,6S)-2,6-Di-iso-propyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2S,6S)-2,6-Di-iso-propyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole HI salt, 1,5,7-Triazabicyclo[4.4.0]dec-5-ene, 1,4,6-Triazabicyclo[3.3.0]oct-4-ene, (4S,5S)-1H-lmidazolium,2- [[(4S,5S)-1,3-dimiethyl-4,5, (S)-a-(Phenylmethyl)-1-pyrrolidinethanamine, (R)-VAPOL HYDROGENPHOSPHATE, (8a,9R)- 10,11-dihydro-Cinchonan-6',9-diol, (9S)-9-(9-phenanthrenyloxy)-Cinchonan-6'-ol, (S)-(–)-a,a-Diphenyl-2-pyrrolidinemethanol trimethylsilyl ether, 2-(diphenylphosphino)-N-(pyridin-2-ylmethyl)ethanamine, (S)-5-Benzyl-2-mesityl-6,6-dimethyl-6,8-dihydro-5H- [1,2,4], (5aR,10bS)-(+)-5a,10b-Dihydro-2-(pentafluorophenyl, (5aS, 10bR)-(-)-5a,10b-Dihydro-2-(pentafluorophe, 1,3-Bis(2,4,6-trimethylphenyl)imidazol-2-ylidene, (S)-5-benzyl-2-phenyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c], (S)-2-[[(1R,2R)-2-AMINOCYCLOHEXYL]THIOUREIDO] -N-BENZYL-N,3,3-TRIMETHYLBUTANAMIDE, (2S)-2-[[[[3,5-Bis(trifluoromethyl) phenyl]amino], 1-[3,5-Bis(trifluoromethyl)phenyl]-3- [(1R,2R)-2-(dimethylamino)cyclohexyl]thiourea, (2S)-2-amino-N,3,3-trimethyl-N-(phenylmethyl)-ButaN/Amide, (S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl) -3-((1R,2R)-2-(dipropylamino)cyclohexyl)thiour, 1-[3,5-Bis(trifluoromethyl)phenyl]-3- [(1S,2S)-2-(dimethylamino)cyclohexyl]thiourea, (S)-2-[[(1R,2R)-2-[[[3,5-Bis(tert-butyl)-2-hydroxyphenyl] methylene]amino]cyclohexyl]thioureido], 2-Propanesulfinamide, N-[(1R,2R)-2-[[[[3,5-bis(trifluoromethyl)phenyl]amino] carbonyl]amino]cycloh, (2S)-3,3-DIMETHYL-2-[[(1R,2R)-2-(2-METHYL-5-PHENYL-1-PYRROLYL) CYCLOHEXYL]THIOUREIDO]-N,N-BIS(2-ISO, (R,R)-(+)-Hydrobenzoin, (2S)-2-Piperidine Methanamine, (2S,3S,4S,5R,6R)-6-bromotetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate, (3S)-3-Thiophenamine, tetrahydro-, 1,1-dioxide, hydrochloride (1:1), (2S,3R)-2-hydroxy-3-(naphthalen-2-ylmethyl)succinic acid1, (R)-2-((S)-2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl) -3-(naphthalen-2-yl)propanoic acid, (S)-4-(3,4-Dichlorophenyl)-3,4-dihydro-1-naphthalenone, 1,4-difluoroanthraquinone
我们的产品与服务
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
GMP
ISO
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
评分
(0)
(0)
(0)
(0)
(0)
评论
筛选：
排序方式：
暂无评论。
留下您的评分和评论